Pembrolizumab combined with chemotherapy for advanced and recurrent endometrial cancer: A single-center retrospective study. // Journal of the Formosan Medical Association. – URL: https://www.sciencedirect.com/science/article/pii/S0929664625005704?dgcid=rss_sd_all
Pembrolizumab combined with chemotherapy for advanced and recurrent endometrial cancer: A single-center retrospective study. Journal of the Formosan Medical Association. https://www.sciencedirect.com/science/article/pii/S0929664625005704?dgcid=rss_sd_all
“Pembrolizumab combined with chemotherapy for advanced and recurrent endometrial cancer: A single-center retrospective study.” Journal of the Formosan Medical Association.
@article{article119102,
title = {Pembrolizumab combined with chemotherapy for advanced and recurrent endometrial cancer: A single-center retrospective study},
journal = {Journal of the Formosan Medical Association},
url = {https://www.sciencedirect.com/science/article/pii/S0929664625005704?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...